Assyro AI

Orange Book product · Generic (ANDA)

SEVELAMER CARBONATE

SEVELAMER CARBONATE

Generic (ANDA)ANDA 203860TE ABRX INVAGEN PHARMS
View SEVELAMER CARBONATE familyOpen on FDA Orange Book

At a glance

Oct 26, 2017

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 26, 2017

    8 yr 9 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SEVELAMER CARBONATE

Strength

800MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 203860

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of SEVELAMER CARBONATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo